Brett R Dees, MD | |
724 24th Ave Nw, Suite 220, Norman, OK 73069-6218 | |
(405) 307-5700 | |
(405) 307-5704 |
Full Name | Brett R Dees |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 17 Years |
Location | 724 24th Ave Nw, Norman, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770789075 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 25616 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Norman Regional | Norman, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Norman Regional Providers Specialty Care | 5496900706 | 138 |
News Archive
The National Cancer Institute has awarded a three-year, $1.4 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researcher Seth M. Noar, PhD, to conduct studies that will help improve the effectiveness of tobacco prevention advertisements for adolescents.
The U.N. on Tuesday "launched a major push to accelerate progress towards the goal of halving, by 2015, the proportion of the population without access to basic sanitation," according to the U.N. News Centre.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
The likelihood of treatment success of 48 wk peg-interferon (PEG-IFN) plus ribavirin (RBV) therapy for chronic hepatitis C may be predicted by viral kinetics on therapy. In particular, recent studies have shown that sustained virological response (SVR) can be predicted by a rapid virological response (RVR), and an early virological response (EVR).
Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.
› Verified 5 days ago
Entity Name | Nrhs Physician Office Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780904953 PECOS PAC ID: 3375732035 Enrollment ID: O20110111000514 |
News Archive
The National Cancer Institute has awarded a three-year, $1.4 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researcher Seth M. Noar, PhD, to conduct studies that will help improve the effectiveness of tobacco prevention advertisements for adolescents.
The U.N. on Tuesday "launched a major push to accelerate progress towards the goal of halving, by 2015, the proportion of the population without access to basic sanitation," according to the U.N. News Centre.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
The likelihood of treatment success of 48 wk peg-interferon (PEG-IFN) plus ribavirin (RBV) therapy for chronic hepatitis C may be predicted by viral kinetics on therapy. In particular, recent studies have shown that sustained virological response (SVR) can be predicted by a rapid virological response (RVR), and an early virological response (EVR).
Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.
› Verified 5 days ago
Entity Name | Norman Regional Providers Specialty Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548513773 PECOS PAC ID: 5496900706 Enrollment ID: O20130312000200 |
News Archive
The National Cancer Institute has awarded a three-year, $1.4 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researcher Seth M. Noar, PhD, to conduct studies that will help improve the effectiveness of tobacco prevention advertisements for adolescents.
The U.N. on Tuesday "launched a major push to accelerate progress towards the goal of halving, by 2015, the proportion of the population without access to basic sanitation," according to the U.N. News Centre.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
The likelihood of treatment success of 48 wk peg-interferon (PEG-IFN) plus ribavirin (RBV) therapy for chronic hepatitis C may be predicted by viral kinetics on therapy. In particular, recent studies have shown that sustained virological response (SVR) can be predicted by a rapid virological response (RVR), and an early virological response (EVR).
Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Brett R Dees, MD Po Box 1330, Norman, OK 73070-1330 Ph: (405) 307-5700 | Brett R Dees, MD 724 24th Ave Nw, Suite 220, Norman, OK 73069-6218 Ph: (405) 307-5700 |
News Archive
The National Cancer Institute has awarded a three-year, $1.4 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researcher Seth M. Noar, PhD, to conduct studies that will help improve the effectiveness of tobacco prevention advertisements for adolescents.
The U.N. on Tuesday "launched a major push to accelerate progress towards the goal of halving, by 2015, the proportion of the population without access to basic sanitation," according to the U.N. News Centre.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
The likelihood of treatment success of 48 wk peg-interferon (PEG-IFN) plus ribavirin (RBV) therapy for chronic hepatitis C may be predicted by viral kinetics on therapy. In particular, recent studies have shown that sustained virological response (SVR) can be predicted by a rapid virological response (RVR), and an early virological response (EVR).
Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.
› Verified 5 days ago
Limei Yang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15951 Little Axe Dr, Norman, OK 73026 Phone: 405-447-0300 Fax: 405-701-7914 | |
Mrs. Dinah Bess L'heureux, PA-C Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2770 Washington Dr Ste 100, Norman, OK 73069 Phone: 405-310-3735 Fax: 405-310-3576 | |
Charito Marcelo, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 320 12th Ave Ne, Norman, OK 73071 Phone: 405-573-3821 Fax: 405-573-8256 | |
Dr. Lori Lynn Hake, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-321-4880 Fax: 405-573-6684 | |
Kanika Manne, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-573-6602 | |
Uzma Zaidi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-573-6602 Fax: 405-573-6684 | |
Dr. Thomas Lee Mcneil, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 N Porter Ave, Suite 212, Norman, OK 73071 Phone: 405-329-5255 Fax: 405-329-5244 |